Dahlke Marc H, Popp Felix C, Larsen Stephen, Schlitt Hans J, Rasko John E J
Gene Therapy Laboratory, Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Australia.
Liver Transpl. 2004 Apr;10(4):471-9. doi: 10.1002/lt.20121.
Various stem cell populations have been described in distinct models of liver regeneration. This review provides an overview of these different stem cell populations aimed at unifying diverse views of liver stem cell biology. Embryonic stem cells, hemopoietic stem cells, mesenchymal stem cells, liver-derived hepatic stem cells, bone marrow-derived hepatic stem cells, and mature hepatocytes (as cells with stemlike properties) are considered separately. In so doing, we seek to clarify the nomenclature of putative liver stem cell types. Experiments that address the question of cellular fusion versus transdifferentiation as explanations for observed liver regeneration are highlighted. This review concludes with a series of open questions that should be addressed in the context of clinical liver disease before attempts at human therapeutic interventions.
在不同的肝脏再生模型中,已描述了多种干细胞群体。本综述概述了这些不同的干细胞群体,旨在统一对肝脏干细胞生物学的不同观点。分别考虑了胚胎干细胞、造血干细胞、间充质干细胞、肝脏来源的肝干细胞、骨髓来源的肝干细胞以及成熟肝细胞(作为具有干细胞样特性的细胞)。通过这样做,我们试图阐明假定的肝干细胞类型的命名法。强调了解决细胞融合与转分化问题以解释观察到的肝脏再生的实验。本综述最后提出了一系列开放性问题,在尝试进行人类治疗干预之前,应在临床肝病的背景下加以解决。